Aspire to ASCENT: Real-world outcomes from patients with metastatic triple-negative breast cancer (mTNBC) treated with Sacituzumab govitecan (Saci) in a single academic institution

被引：1
|
作者：
Walsh, E. M.
Klar, M. [1 ]
Abuhadra, N. [1 ]
Robson, M. [1 ]
Drago, J. [1 ]
机构：
[1] Evelyn H Lauder Breast Ctr, Breast Med Serv, Mem Sloan Kettering Canc Ctr, New York, NY USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419P
引用
收藏
页码：S359 / S359
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes in patients (pts) with metastatic triple-negative breast cancer (mTNBC) treated with sacituzumab govitecan (SG) in 2L+in the United States (US)
    Kalinsky, Kevin
    Spring, Laura
    Yam, Clinton
    Taylor, Aliki
    Sjekloca, Nikoleta
    Kaushiva, Alpana
    Lai, Catherine
    Ntalla, Ioanna
    Nanda, Rita
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] SARELIFE: An Italian, multicentric real-world study of sacituzumab govitecan (SG) in pretreated metastatic triple-negative breast cancer (mTNBC)
    Cona, M. S.
    Ruggieri, L.
    Artale, S. A. A.
    Catania, G.
    D'Auria, G.
    Gallerani, E.
    Villa, F.
    Gambaro, A.
    Chirco, A.
    Giordano, M.
    Pistelli, M.
    Verderame, F.
    Bramati, A.
    Stani, S. C.
    Vici, P.
    Meattini, I.
    Tagliaferri, B.
    Tedesco, B.
    Amato, O.
    La Verde, N. M.
    ANNALS OF ONCOLOGY, 2024, 35 : S381 - S382
  • [3] Real World Outcomes with Sacituzumab Govitecan in Metastatic Triple Negative Breast Cancer Patients: A Multi-Institution Study
    Alaklabi, Sabah
    Roy, Arya Mariam
    Zagami, Paola
    Held, Nicole
    Shaikh, Saba
    Chaudhary, Lubna
    Abdou, Yara
    Gandhi, Shipra
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Assessment of sacituzumab govitecan (SG) in Black patients (pts) from the phase 3 ASCENT study in metastatic triple-negative breast cancer (mTNBC)
    Carey, Lisa A.
    Zelnak, Amelia
    Rugo, Hope S.
    Dalenc, Florence
    Nanda, Rita
    Danso, Michael
    Saghatchian, Mahasti
    Kalinsky, Kevin
    Firmin, Nelly
    Ruiz-Borrego, Manuel
    Favret, Anne
    Sun, Jun
    Schwartzberg, Lee
    Hilton, Christie
    Omene, Coral
    Young, Robyn
    Hurvitz, Sara A.
    Harting, Eliza
    Phan, See
    Bardia, Aditya
    CANCER RESEARCH, 2022, 82 (04)
  • [5] Outcomes in patients (pts) aged ≥65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
    Hegewisch-Becker, S.
    Oliveira, M.
    Traina, T.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Hurvitz, S. A.
    Lynce, F.
    Hamilton, E.
    Nanda, R.
    Hart, L.
    Richards, P.
    Malik, Z.
    Rugo, H. S.
    Dieras, V
    Bardia, A.
    Hong, Q.
    Phan, S.
    Itri, L. M.
    Loibl, S.
    Kalinsky, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 242 - 242
  • [6] Outcomes in patients (pts) aged ≥65 years in the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC).
    Kalinsky, Kevin
    Oliveira, Mafalda
    Traina, Tiffany A.
    Tolaney, Sara M.
    Loirat, Delphine
    Punie, Kevin
    Hurvitz, Sara A.
    Lynce, Filipa
    Hamilton, Erika P.
    Nanda, Rita
    Hart, Lowell L.
    Richards, Paul D.
    Malik, Zulfiqar A.
    Rugo, Hope S.
    Dieras, Veronique
    Bardia, Aditya
    Hong, Quan
    Olivo, Martin Sebastian
    Itri, Loretta
    Loibl, Sibylle
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Metastatic triple-negative Breast Cancer (mTNBC) First-in-class Therapy with Sacituzumab Govitecan
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (1-2) : 64 - 65
  • [8] Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Hurvitz, S. A.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Oliveira, M.
    Brufsky, A.
    Sardesai, S. D.
    Kalinsky, K.
    Zelnak, A. B.
    Weaver, R.
    Traina, T.
    Dalenc, F.
    Aftimos, P.
    Lynce, F.
    Diab, S.
    Cortes, J.
    O'Shaughnessy, J.
    Dieras, V
    Ferrario, C.
    Schmid, P.
    Carey, L. A.
    Gianni, L.
    Piccart, M. J.
    Loibl, S.
    Goldenberg, D. M.
    Hong, Q.
    Olivo, M. S.
    Itri, L. M.
    Rugo, H. S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (16): : 1529 - 1541
  • [9] Metastatic triple-negative breast cancer (mTNBC) first-in-class therapy with sacituzumab govitecan
    Schoellmann, Claudia
    BREAST CARE, 2022, 17 (01)
  • [10] Post-progression therapy outcomes in patients (pts) from the phase 3 ASCENT study of sacituzumab govitecan (SG) in metastatic triple-negative breast cancer (mTNBC)
    Cortes, Javier
    Bardia, Aditya
    Loirat, Delphine
    Tolaney, Sara M.
    Punie, Kevin
    Oliveira, Mafalda
    Hurvitz, Sara A.
    Brufsky, Adam
    Sardesai, Sagar
    Kalinsky, Kevin M.
    Traina, Tiffany
    Hamilton, Erika
    O'Shaughnessy, Joyce
    Dieras, Veronique
    Carey, Lisa A.
    Piccart, Martine
    Loibl, Sibylle
    Rugo, Hope S.
    Zhu, Yanni
    Phan, See
    Gianni, Luca
    CANCER RESEARCH, 2022, 82 (04)
12345